Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00121329
Status:
COMPLETED
Last Update Posted:
2005-07-21
First Post:
2005-07-13
Brief Title:
4 Intrauterine Lidocaine Infusion for Pain Management in First Trimester Abortions
Sponsor:
Oregon Health and Science University
Organization:
Oregon Health and Science University
Study Overview
Official Title:
4 Intrauterine Lidocaine Infusion for Pain Management in First Trimester Abortions
Status:
COMPLETED
Status Verified Date:
2005-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Recent studies have investigated the use of local anesthetics ie lidocaine mepivacaine to lessen the pain experienced with minor gynecologic procedures such as endometrial biopsy and office hysteroscopy Local anesthetic injected into the uterine cavity has been demonstrated effective in some studies at decreasing patient pain associated with these intrauterine procedures at an anesthetic concentration of at least 2 Based on this evidence we hypothesized that an intrauterine lidocaine infusion may reduce patient pain during first trimester abortions
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None